MRC1 and cancer: Therefore, this effect may be either the result of telomere shortening in cancer-affected individuals, or a marker of increased cancer risk among MMR gene mutation carriers, supporting the idea that short telomere length or accelerated telomere attrition rate are factors of increased cancer risk in LS.